Journal
TRANSACTIONS OF THE ROYAL SOCIETY OF TROPICAL MEDICINE AND HYGIENE
Volume 115, Issue 5, Pages 447-456Publisher
OXFORD UNIV PRESS
DOI: 10.1093/trstmh/trab045
Keywords
2019 novel coronavirus disease clinical trial; COVID-19; low- and middle-income countries; severe acute respiratory syndrome coronavirus 2; vaccines
Ask authors/readers for more resources
The COVID-19 pandemic poses the biggest threat to public health in a century. While scientists have developed safe and effective vaccines, there is a global disparity in vaccine distribution due to high demand and limited supply. This review highlights the challenges faced by low- and middle-income countries in accessing and distributing COVID-19 vaccines.
The COVID-19 pandemic is the biggest threat to public health in a century. Through hard work and ingenuity, scientists have developed a number of safe and effective vaccines against COVID-19 disease. However, demand far outstrips supply and countries around the world are competing for available vaccines. This review describes how low- and middle-income countries access COVID-19 vaccines, what is being done to distribute vaccines fairly, as well as the challenges ahead.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available